To understand the gaps in U.S. pharma companies' operations and their priorities during COVID-19, we designed and carried out our inaugural operations excellence and transformation study. The study provided us insight into the current state of our clients’ operations, as well as the future of these operations.


See the infographic below for a quick summary of our findings, or download the report (on the right) for a deeper dive.